<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="574" height="447" viewBox="0 0 574 447"><rect width="574" height="447" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(64,87)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h500v300h-500Z" stroke="lightgray" stroke-width="0.5"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,300)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,267)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,233)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,200)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,167)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,133)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,67)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,33)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 13 values: 0, 1, 2, 3, 4, ending with 12"><g transform="translate(0.5,300.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(19,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(57,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(96,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(134,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(173,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(211,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(250,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(288,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(326,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(365,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(403,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(442,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(480,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(18.73076923076924,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(57.1923076923077,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">1</text><text text-anchor="end" transform="translate(95.65384615384616,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">2</text><text text-anchor="end" transform="translate(134.11538461538464,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">3</text><text text-anchor="end" transform="translate(172.5769230769231,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">4</text><text text-anchor="end" transform="translate(211.03846153846155,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">5</text><text text-anchor="end" transform="translate(249.5,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">6</text><text text-anchor="end" transform="translate(287.9615384615385,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">7</text><text text-anchor="end" transform="translate(326.42307692307696,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">8</text><text text-anchor="end" transform="translate(364.8846153846154,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">9</text><text text-anchor="end" transform="translate(403.34615384615387,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">10</text><text text-anchor="end" transform="translate(441.8076923076923,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">11</text><text text-anchor="end" transform="translate(480.2692307692308,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">12</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="500" y2="0" stroke="black" stroke-width="0.5" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Number of Participants' for a linear scale with values from 0 to 180"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,300)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,267)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,233)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,200)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,167)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,133)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,67)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,33)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,303)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(-7,269.66666666666663)" font-family="Arial" font-size="11px" fill="black" opacity="1">20</text><text text-anchor="end" transform="translate(-7,236.33333333333334)" font-family="Arial" font-size="11px" fill="black" opacity="1">40</text><text text-anchor="end" transform="translate(-7,203.00000000000003)" font-family="Arial" font-size="11px" fill="black" opacity="1">60</text><text text-anchor="end" transform="translate(-7,169.66666666666669)" font-family="Arial" font-size="11px" fill="black" opacity="1">80</text><text text-anchor="end" transform="translate(-7,136.33333333333331)" font-family="Arial" font-size="11px" fill="black" opacity="1">100</text><text text-anchor="end" transform="translate(-7,103.00000000000001)" font-family="Arial" font-size="11px" fill="black" opacity="1">120</text><text text-anchor="end" transform="translate(-7,69.66666666666666)" font-family="Arial" font-size="11px" fill="black" opacity="1">140</text><text text-anchor="end" transform="translate(-7,36.33333333333335)" font-family="Arial" font-size="11px" fill="black" opacity="1">160</text><text text-anchor="end" transform="translate(-7,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">180</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,300)" x2="0" y2="-300" stroke="black" stroke-width="0.5" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-40.35302734375,150) rotate(-90) translate(0,-3)" font-family="Arial" font-size="12px" font-weight="bold" fill="black" opacity="1">Number of Participants</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark layer_0_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Stage: 0; Number of Participants: 78; Diagnosis: CN; Count: 78; Percentage: 44.1%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,170h34.61538461538461v130h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 0; Number of Participants: 64; Diagnosis: EMCI; Count: 64; Percentage: 36.2%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,63.33333333333334h34.61538461538461v106.66666666666666h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 0; Number of Participants: 35; Diagnosis: LMCI; Count: 35; Percentage: 19.8%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,5.000000000000016h34.61538461538461v58.33333333333333h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 0; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 2; Number of Participants: 53; Diagnosis: CN; Count: 53; Percentage: 40.5%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,211.66666666666666h34.61538461538461v88.33333333333334h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 2; Number of Participants: 55; Diagnosis: EMCI; Count: 55; Percentage: 42.0%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,120h34.61538461538461v91.66666666666666h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 2; Number of Participants: 23; Diagnosis: LMCI; Count: 23; Percentage: 17.6%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,81.66666666666667h34.61538461538461v38.33333333333333h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 3; Number of Participants: 5; Diagnosis: CN; Count: 5; Percentage: 26.3%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,290h34.61538461538461v8.333333333333314h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 3; Number of Participants: 6; Diagnosis: EMCI; Count: 6; Percentage: 31.6%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,280h34.61538461538461v10h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 3; Number of Participants: 7; Diagnosis: LMCI; Count: 7; Percentage: 36.8%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,268.33333333333337h34.61538461538461v11.666666666666629h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 3; Number of Participants: 1; Diagnosis: AD; Count: 1; Percentage: 5.3%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,298.3333333333333h34.61538461538461v1.6666666666666856h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 4; Number of Participants: 1; Diagnosis: EMCI; Count: 1; Percentage: 100.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,298.3333333333333h34.61538461538461v1.6666666666666856h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,298.3333333333333h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 5; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 14.3%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,296.6666666666667h34.61538461538461v1.6666666666666288h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 5; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 42.9%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,291.6666666666667h34.61538461538461v5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 5; Number of Participants: 2; Diagnosis: LMCI; Count: 2; Percentage: 28.6%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,288.3333333333333h34.61538461538461v3.3333333333333712h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 5; Number of Participants: 1; Diagnosis: AD; Count: 1; Percentage: 14.3%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,298.3333333333333h34.61538461538461v1.6666666666666856h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 6; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 5.6%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,293.3333333333333h34.61538461538461v1.6666666666666856h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 6; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 16.7%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,288.3333333333333h34.61538461538461v5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 6; Number of Participants: 11; Diagnosis: LMCI; Count: 11; Percentage: 61.1%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,270h34.61538461538461v18.333333333333314h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 6; Number of Participants: 3; Diagnosis: AD; Count: 3; Percentage: 16.7%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,295h34.61538461538461v5h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 7; Number of Participants: 6; Diagnosis: CN; Count: 6; Percentage: 40.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,290h34.61538461538461v10h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 7; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 20.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,285h34.61538461538461v5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 7; Number of Participants: 6; Diagnosis: LMCI; Count: 6; Percentage: 40.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,275h34.61538461538461v10h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 7; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 8; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 8; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,295h34.61538461538461v5h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 8; Number of Participants: 3; Diagnosis: LMCI; Count: 3; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,290h34.61538461538461v5h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 8; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 9; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,271.6666666666667h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 9; Number of Participants: 1; Diagnosis: EMCI; Count: 1; Percentage: 2.9%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,270h34.61538461538461v1.6666666666666856h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 9; Number of Participants: 17; Diagnosis: LMCI; Count: 17; Percentage: 48.6%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,241.66666666666669h34.61538461538461v28.333333333333314h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 9; Number of Participants: 17; Diagnosis: AD; Count: 17; Percentage: 48.6%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,271.6666666666667h34.61538461538461v28.333333333333314h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 10; Number of Participants: 4; Diagnosis: CN; Count: 4; Percentage: 3.8%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,240h34.61538461538461v6.666666666666657h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 10; Number of Participants: 26; Diagnosis: EMCI; Count: 26; Percentage: 24.8%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,196.66666666666666h34.61538461538461v43.33333333333334h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 10; Number of Participants: 43; Diagnosis: LMCI; Count: 43; Percentage: 41.0%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,124.99999999999999h34.61538461538461v71.66666666666667h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 10; Number of Participants: 32; Diagnosis: AD; Count: 32; Percentage: 30.5%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,246.66666666666666h34.61538461538461v53.33333333333334h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 11; Number of Participants: 4; Diagnosis: CN; Count: 4; Percentage: 4.3%" role="graphics-symbol" aria-roledescription="bar" d="M425,223.33333333333334h34.61538461538461v6.666666666666629h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 11; Number of Participants: 4; Diagnosis: EMCI; Count: 4; Percentage: 4.3%" role="graphics-symbol" aria-roledescription="bar" d="M425,216.66666666666666h34.61538461538461v6.666666666666686h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 11; Number of Participants: 44; Diagnosis: LMCI; Count: 44; Percentage: 46.8%" role="graphics-symbol" aria-roledescription="bar" d="M425,143.33333333333331h34.61538461538461v73.33333333333334h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 11; Number of Participants: 42; Diagnosis: AD; Count: 42; Percentage: 44.7%" role="graphics-symbol" aria-roledescription="bar" d="M425,229.99999999999997h34.61538461538461v70.00000000000003h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 12; Number of Participants: 3; Diagnosis: CN; Count: 3; Percentage: 2.5%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,200.00000000000003h34.61538461538461v4.999999999999972h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 12; Number of Participants: 13; Diagnosis: EMCI; Count: 13; Percentage: 11.0%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,178.33333333333334h34.61538461538461v21.666666666666686h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 12; Number of Participants: 45; Diagnosis: LMCI; Count: 45; Percentage: 38.1%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,103.33333333333333h34.61538461538461v75.00000000000001h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 12; Number of Participants: 57; Diagnosis: AD; Count: 57; Percentage: 48.3%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,205h34.61538461538461v95h-34.61538461538461Z" fill="#EE6677"/></g><g class="mark-text role-mark layer_1_marks" role="graphics-object" aria-roledescription="text mark container"><text aria-label="Stage: 0; Total: 177; Total Sample Size: 177" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">177</text><text aria-label="Stage: 0; Total: 177; Total Sample Size: 177" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">177</text><text aria-label="Stage: 0; Total: 177; Total Sample Size: 177" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">177</text><text aria-label="Stage: 0; Total: 177; Total Sample Size: 177" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">177</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 2; Total: 131; Total Sample Size: 131" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">131</text><text aria-label="Stage: 2; Total: 131; Total Sample Size: 131" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">131</text><text aria-label="Stage: 2; Total: 131; Total Sample Size: 131" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">131</text><text aria-label="Stage: 2; Total: 131; Total Sample Size: 131" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">131</text><text aria-label="Stage: 3; Total: 19; Total Sample Size: 19" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">19</text><text aria-label="Stage: 3; Total: 19; Total Sample Size: 19" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">19</text><text aria-label="Stage: 3; Total: 19; Total Sample Size: 19" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">19</text><text aria-label="Stage: 3; Total: 19; Total Sample Size: 19" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">19</text><text aria-label="Stage: 4; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 4; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 4; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 4; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 5; Total: 7; Total Sample Size: 7" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">7</text><text aria-label="Stage: 5; Total: 7; Total Sample Size: 7" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">7</text><text aria-label="Stage: 5; Total: 7; Total Sample Size: 7" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">7</text><text aria-label="Stage: 5; Total: 7; Total Sample Size: 7" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">7</text><text aria-label="Stage: 6; Total: 18; Total Sample Size: 18" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">18</text><text aria-label="Stage: 6; Total: 18; Total Sample Size: 18" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">18</text><text aria-label="Stage: 6; Total: 18; Total Sample Size: 18" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">18</text><text aria-label="Stage: 6; Total: 18; Total Sample Size: 18" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">18</text><text aria-label="Stage: 7; Total: 15; Total Sample Size: 15" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">15</text><text aria-label="Stage: 7; Total: 15; Total Sample Size: 15" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">15</text><text aria-label="Stage: 7; Total: 15; Total Sample Size: 15" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">15</text><text aria-label="Stage: 7; Total: 15; Total Sample Size: 15" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">15</text><text aria-label="Stage: 8; Total: 6; Total Sample Size: 6" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">6</text><text aria-label="Stage: 8; Total: 6; Total Sample Size: 6" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">6</text><text aria-label="Stage: 8; Total: 6; Total Sample Size: 6" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">6</text><text aria-label="Stage: 8; Total: 6; Total Sample Size: 6" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">6</text><text aria-label="Stage: 9; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 9; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 9; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 9; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 10; Total: 105; Total Sample Size: 105" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">105</text><text aria-label="Stage: 10; Total: 105; Total Sample Size: 105" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">105</text><text aria-label="Stage: 10; Total: 105; Total Sample Size: 105" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">105</text><text aria-label="Stage: 10; Total: 105; Total Sample Size: 105" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">105</text><text aria-label="Stage: 11; Total: 94; Total Sample Size: 94" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">94</text><text aria-label="Stage: 11; Total: 94; Total Sample Size: 94" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">94</text><text aria-label="Stage: 11; Total: 94; Total Sample Size: 94" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">94</text><text aria-label="Stage: 11; Total: 94; Total Sample Size: 94" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">94</text><text aria-label="Stage: 12; Total: 118; Total Sample Size: 118" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">118</text><text aria-label="Stage: 12; Total: 118; Total Sample Size: 118" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">118</text><text aria-label="Stage: 12; Total: 118; Total Sample Size: 118" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">118</text><text aria-label="Stage: 12; Total: 118; Total Sample Size: 118" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">118</text></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend for fill color with 4 values: CN, EMCI, LMCI, AD"><g transform="translate(0,-29)"><path class="background" aria-hidden="true" d="M0,0h181v11h-181Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h31.8876953125v11h-31.8876953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#4477AA" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">CN</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(42,0)"><path class="background" aria-hidden="true" d="M0,0h43.5v11h-43.5Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#66CCEE" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">EMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(96,0)"><path class="background" aria-hidden="true" d="M0,0h42.28076171875v11h-42.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#228833" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">LMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(149,0)"><path class="background" aria-hidden="true" d="M0,0h31.28076171875v11h-31.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#EE6677" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">AD</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-title"><g transform="translate(250,-47)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Distribution of Disease Stages by Diagnosis, DEBM'" pointer-events="none"><text text-anchor="middle" transform="translate(0,1)" font-family="sans-serif" font-size="14px" font-weight="normal" fill="#000" opacity="1">Distribution of Disease Stages by Diagnosis, DEBM</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>